Science Explorer Back to mapMap
Discussion
Researcher · Lexicon Pharmaceuticals (United States) · United States

Brian D. Hamman

Brian D. Hamman publishes mostly in Molecular Biology, Oncology and Physiology, on topics such as RNA and protein synthesis mechanisms, Protein Degradation and Inhibitors and Chromatin Remodeling and Cancer.

OpenAlex
World rank
#618,772
of 7,710,434 ranked researchers
Rank in United States
#211,724
of 1,627,098
Works
39
Citations
4.1k
Citations per work
106.1
h-index
23
i10-index 28Top 26% in Molecular Biology
Brian D. Hamman

What does Brian D. Hamman research?

Brian D. Hamman's work is mostly in Biochemistry, Genetics and Molecular Biology (42%), Medicine (15%), Social Sciences (4%).

Life Sciences: 16 works · 42.3% of their workBiochemistry, Genetics and Molecular Biology: 16 works · 42.3% of their workMolecular Biology: 15 works · 37.8% of their workCell Biology: 2 works · 4.5% of their workEverything else: 15 works · 37.9% of their workHealth Sciences: 6 works · 15.3% of their workMedicine: 6 works · 15.3% of their workOncology: 3 works · 7.2% of their workPhysiology: 2 works · 4.5% of their workNeurology: 1 works · 3.6% of their workSocial Sciences: 2 works · 4.5% of their workSocial Sciences: 2 works · 4.5% of their workCommunication: 2 works · 4.5% of their workTHEIR WORKBrian D. Hamman39works
Life Sciences42%Health Sciences15%Social Sciences4%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1642.3%
  2. Everything else1537.9%
    1. Medicine615.3%
    1. Social Sciences24.5%
  1. 1Molecular Biology38% of their works
  2. 2Oncology7% of their works
  3. 3Physiology4% of their works
  4. 4Cell Biology4% of their works
  5. 5Communication4% of their works
  6. 6Neurology4% of their works

Research topics

Which keywords describe Brian D. Hamman's research?

The keywords of their largest research topics: Cancer Therapy, Transcriptional Regulation, Ribosome, Translation, BET Bromodomains, PROTACs, Central Sensitization and Chromatin Remodeling.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer Therapy103 topics
  2. Transcriptional Regulation102 topics
  3. Ribosome81 topic
  4. Translation81 topic
  5. BET Bromodomains71 topic
  6. PROTACs71 topic
  7. Central Sensitization51 topic
  8. Chromatin Remodeling51 topic
  9. Neuropathic Pain51 topic
  10. SWI/SNF Complexes51 topic
  11. Bacterial Physiology41 topic
  12. Fibroblast Activation Protein41 topic
  13. Gene Regulation41 topic
  14. Tumor Microenvironment41 topic
  15. Proteasome31 topic
  16. Protein Kinases31 topic
  17. Ras Signaling31 topic
  18. Ubiquitin31 topic

Where does Brian D. Hamman work?

Brian D. Hamman's main affiliation in the publication record is Lexicon Pharmaceuticals (United States), United States.

How many publications and citations does Brian D. Hamman have?

OpenAlex counts 39 works and 4,137 citations for Brian D. Hamman, an h-index of 23, ranking #618,772 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Brian D. Hamman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.